Transforming HCV Management in the Pretransplant and Posttransplant Settings: The Role of New Agents

Download slides, review ClinicalThought commentaries, and then participate in the conversation surrounding the use of DAA HCV therapy in liver transplant patients.
Nezam H. Afdhal, MD, FRCPI
Paul Y. Kwo, MD
John Roberts, MD

CCO Slidesets

In this downloadable slideset, Paul Y. Kwo, MD, reviews current and forthcoming options for interferon-free treatment of pretransplantation and posttransplantation patients with HCV.

Released: September 15, 2014

In this downloadable slideset, Jean C. Edmond, MD, offers insight into managing HCV in pretransplant and posttransplant patients.

Released: September 15, 2014

In this downloadable slideset, Norah Terrault, MD, MPH, leads a review of a series of cases with Jean C. Emond, MD, and Paul Y. Kwo, MD, evaluating the optimal use of available HCV therapies in the pretransplantation and posttransplantation patients.

Released: September 16, 2014

Clinical Thoughts

Paul Y. Kwo, MD, introduces some of the topics that will be discussed in an upcoming symposium in San Francisco.

Paul Y. Kwo, MD Released: July 10, 2014

Now that highly tolerable, highly effective HCV treatments are available, treatment in the pretransplant setting is a viable approach for many patients currently on the waitlist. Does this approach have a downside?

John Roberts, MD Released: April 24, 2015

In starting HCV treatment after liver transplant, how soon is soon enough?

Nezam H. Afdhal, MD, FRCPI Released: April 7, 2015

Will we finally have options to prevent posttransplantation HCV recurrence across the spectrum of genotypes?

Paul Y. Kwo, MD Released: July 29, 2015
Jointly provided/cosponsored/coprovided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)

This activity is supported by an independent educational grant from
Gilead Sciences

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?